Waystar (NASDAQ:WAY - Get Free Report) had its price objective decreased by research analysts at Citigroup from $35.00 to $30.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Citigroup's price target would indicate a potential upside of 44.11% from the stock's current price.
A number of other brokerages have also recently issued reports on WAY. Bank of America reduced their target price on shares of Waystar from $45.00 to $38.00 and set a "buy" rating for the company in a research report on Friday, April 10th. TD Cowen reiterated a "buy" rating on shares of Waystar in a research note on Wednesday, February 18th. Loop Capital set a $33.00 price objective on shares of Waystar in a report on Wednesday, February 18th. Truist Financial lowered their target price on shares of Waystar from $51.00 to $38.00 and set a "buy" rating on the stock in a report on Wednesday, February 18th. Finally, Weiss Ratings downgraded shares of Waystar from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Tuesday, March 10th. Three analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $36.14.
View Our Latest Analysis on Waystar
Waystar Stock Performance
Shares of WAY traded down $0.06 during trading hours on Tuesday, hitting $20.82. The company had a trading volume of 516,654 shares, compared to its average volume of 2,645,486. The business has a fifty day moving average of $24.57 and a 200-day moving average of $29.65. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.37. The firm has a market cap of $3.99 billion, a price-to-earnings ratio of 31.09, a PEG ratio of 0.80 and a beta of 0.21. Waystar has a 12 month low of $20.35 and a 12 month high of $42.55.
Waystar (NASDAQ:WAY - Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.39 by $0.03. The company had revenue of $313.87 million during the quarter, compared to analysts' expectations of $311.74 million. Waystar had a return on equity of 6.99% and a net margin of 10.90%.The business's revenue was up 22.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.32 earnings per share. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Equities analysts anticipate that Waystar will post 1.46 EPS for the current fiscal year.
Institutional Trading of Waystar
Institutional investors and hedge funds have recently made changes to their positions in the company. Salomon & Ludwin LLC acquired a new stake in shares of Waystar during the 3rd quarter worth approximately $25,000. Root Financial Partners LLC lifted its stake in Waystar by 6,475.0% during the first quarter. Root Financial Partners LLC now owns 1,052 shares of the company's stock worth $25,000 after purchasing an additional 1,036 shares during the last quarter. ANTIPODES PARTNERS Ltd boosted its holdings in shares of Waystar by 120.1% in the 3rd quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company's stock valued at $31,000 after purchasing an additional 449 shares in the last quarter. First Horizon Corp acquired a new stake in shares of Waystar in the 3rd quarter valued at $38,000. Finally, Smartleaf Asset Management LLC increased its stake in shares of Waystar by 6,005.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,160 shares of the company's stock valued at $38,000 after purchasing an additional 1,141 shares during the last quarter.
Waystar Company Profile
(
Get Free Report)
Waystar NASDAQ: WAY is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company's unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar's offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Waystar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waystar wasn't on the list.
While Waystar currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.